Although EML4-ALK with different fusion breakpoints in EML4 gene remains the major fusion variant in ALK-rearranged NSCLC, at least other 90 distinct fusion partners have been identified with NGS method in ALK-rearranged NSCLC [21]. Here, ALK is linked to non-small cell lung carcinoma.